Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus

被引：0
|
作者：
Boulmpou, A. [1 ]
Patoulias, D. [2 ]
Teperikidis, E. [1 ]
Tsavousoglou, C. [1 ]
Vergopoulos, S. [1 ]
Toumpourleka, M. [1 ]
Doumas, M. [2 ]
Fragakis, N. [1 ]
Vassilikos, V. [1 ]
Papadopoulos, C. E. [1 ]
机构：
[1] Hippokrat Gen Hosp Thessaloniki, Dept Cardiol 3, Thessaloniki, Greece
[2] Hippokrat Gen Hosp Thessaloniki, Propedeut Dept Internal Med 2, Thessaloniki, Greece
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2955 / 2955
页数：1
相关论文
共 50 条
  • [41] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Kim, Young-Gun
    Kim, Seirhan
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [42] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Xin Wei
    Yu Bai
    Zhuo Wang
    Xiaohong Zheng
    Zening Jin
    Xin Liu
    Diabetology & Metabolic Syndrome, 13
  • [43] The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
    Yousefzadeh, Pegah
    Wang, Xiangbing
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [44] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [45] Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes
    Faillie, J. -L.
    Filion, K. B.
    Patenaude, V.
    Ernst, P.
    Azoulay, L.
    DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 379 - 385
  • [46] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [47] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [48] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
  • [49] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [50] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
    Deacon, Carolyn F.
    Holst, Jens J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2047 - 2058
12345